US Bancorp’s Achillion Pharmaceuticals ACHN Stock Holding History

US Bancorp’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,000	Closed	-$12K	–	3916
2019 Q4	$12K	Buy	+2,000	New	+$11.6K	﹤0.01%	3060
2017 Q1	–	Sell	-82	Closed	–	–	3686
2016 Q4	$0	Buy	+82	New	+$436	﹤0.01%	3696
2015 Q2	–	Sell	-482	Closed	-$5K	–	3684
2015 Q1	$5K	Hold	482	–	–	﹤0.01%	3303
2014 Q4	$6K	Buy	+482	New	+$5.89K	﹤0.01%	3243
2013 Q3	–	Sell	-4,319	Closed	-$35K	–	3368
2013 Q2	$35K	Buy	+4,319	New	+$33K	﹤0.01%	2444

US Bancorp's ACHN Position: Q1 2020 in Review

US Bancorp sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 2,000 shares — an estimated $12K sold.

US Bancorp first reported a position in ACHN in Q2 2013 and held it in 5 quarters. The position peaked at $35K in Q2 2013. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

US Bancorp reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
US Bancorp sold 2,000 Achillion Pharmaceuticals shares in Q1 2020, an estimated $12K.
US Bancorp first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 5 quarters.
US Bancorp's Achillion Pharmaceuticals position peaked at $35K in Q2 2013.
0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on US Bancorp's 13F filing for Q1 2020, filed 13 May 2020.